Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lauren K. Somes
Observed names:
L. K. Somes,
Lauren Kelly,
Lauren M. Kelly,
Lauren Somes
Institution:
Baylor College of Medicine
Observed institutions:
Houston Methodist,
Baylor College of Medicine,
Texas Children's Hospital,
Dan L Duncan Comprehensive Cancer Center
ORCID:
0000-0002-1788-9622
Observed ORCID:
0000-0002-1788-9622
OpenAlex ID:
A5005708528
Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
2022
·
Paul Shafer
, Lauren M. Kelly
, et al.
·
Frontiers in Immunology
·
329
PDF
Pan-cancer proteogenomics expands the landscape of therapeutic targets
2024
·
Sara R. Savage
, Xinpei Yi
, et al.
·
Cell
·
149
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
2021
·
Saisha A Nalawade
, Paul Shafer
, et al.
·
Journal for ImmunoTherapy of Cancer
·
85
PDF
Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential
2023
·
Diego F. Chamorro
, Lauren K. Somes
, et al.
·
Cancers
·
25
PDF
Incongruity between T cell receptor recognition of breast cancer hotspot mutations ESR1 Y537S and D538G following exogenous peptide loading versus endogenous antigen processing
2024
·
Paul Shafer
, Wingchi K. Leung
, et al.
·
Cytotherapy
·
5
PDF
ZP4: A novel target for CAR-T cell therapy in triple negative breast cancer
2025
·
Lauren K. Somes
, Jonathan T. Lei
, et al.
·
Molecular Therapy
·
4
NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis
2026
·
Zifan Zhao
, Ze-Yi Zheng
, et al.
·
Cancer Letters
·
3
Abstract 3482: Enhanced targeting of HPV positive cancers using gamma delta 1 T cells armored with an HPV E7-specific TCR: a novel approach to overcome HLA downregulation
2025
·
Andres Mosquera
, Diego F. Chamorro
, et al.
·
Cancer Research
·
1
Abstract PO5-04-06: Enhancing Antitumor Activity of Her2 CAR T cells through TR2BB Co-Expression and Cytokine Signal 3 Incorporation
2024
·
Diego Chamorro
, Lauren Somes
, et al.
·
Cancer Research
·
1
Abstract 5726: Pan-cancer proteogenomics expands the landscape of therapeutic targets
2023
·
Jonathan T. Lei
, Sara R. Savage
, et al.
·
Cancer Research
·
1
Corrigendum to “NF1 loss in estrogen receptor-positive breast cancer induces osteoclast formation and immunosuppression to promote bone metastasis” [Cancer Lett. 655 (2026) 218636]
2026
·
Zifan Zhao
, Ze-Yi Zheng
, et al.
·
Cancer Letters
PDF
Abstract PS1-12-26: Neurofibromin loss as a driver of bone metastasis in estrogen receptor-positive breast cancer
2026
·
Z. Zhao
, Z. Zheng
, et al.
·
Clinical Cancer Research
Abstract PO4-06-08: ZP4 AS A NOVEL TARGET FOR CAR T CELL THERAPY IN TRIPLE NEGATIVE BREAST CANCER
2024
·
Lauren Somes
, Jonathan Lei
, et al.
·
Cancer Research
Show more works
View as search
Works count:
13
Citation count:
603
H-index:
5
I10-index:
4
Year
Topic
Type